Counseling Patients with EGFR-Mutant NSCLC and Shared Decision-Making

Panelists discuss how transparent communication about central nervous system response expectations and overall treatment goals builds patient trust and engagement. When counseling individuals with brain metastases, physicians must balance optimism about modern therapies with realistic discussions about disease trajectory and symptom control.

They highlight the importance of shared decision-making, where patient preferences guide the final treatment choice among comparable options. This process involves explaining differences in drug administration, adverse effect profiles, and long-term strategies, ensuring patients feel ownership of their care.

Quality of life emerges as a central theme, with panelists emphasizing that patient-reported outcomes and psychosocial support are integral to sustained adherence. By aligning clinical goals with patient priorities, providers can foster both satisfaction and optimal outcomes.